Subscriber login:
Remember me
FEDERAL AND STATE LEGISLATION TRACKING
Federal Legislation & Government Insights Tracking and Coverage
Gain access to reports and strategic insights written by our team of legal analysts, clinical pharmacists, and senior researchers covering legislation and government-related lawsuits that may have an impact on drug pricing, patient access, drug reimbursement, and intellectual property covering drug products.
Focused on high-impact bills, rules, regulations, executive orders, and government-related lawsuits, our Legislation & Government Insights will help you understand their potential effects on the marketplace and healthcare stakeholders.
In addition to comprehensive reports and real-time email updates following legislation moving through the House of Representatives or Senate and being challenged in court, our High-Impact Legislation & Government Insights Tracker allows you to easily monitor statuses, outcomes, and important details of each ongoing situation.
State Legislation & Government Insights Tracking and Coverage
Track current and proposed state legislation impacting payer coverage, drug pricing, utilization management, pharmacy benefit managers, pharmacy practices, and more with access to state-by-state topic coverage, data visualizations, source information, and consults with our expert team.
Explore Recent Reports
November 2025
Federal Pre-emption of State Laws Concerning Covered Entities’ Contract Pharmacy Usage Under the 340B Program
IPD Analytics has released a new State Legislation and Government Insights report, “Federal Pre-emption of State Laws Concerning Covered Entities’ Contract Pharmacy Usage Under the 340B Program,” which examines the ongoing disputes over covered entities’ use of multiple contract pharmacies under the 340B Program. While most courts have ruled in favor of the states, ongoing lawsuits and HHS policy shifts leave the future uncertain.
The report details 21 key state legal cases, court outcomes, and implications for payers, providers, and manufacturers.
August 2025
The One Big Beautiful Bill Act’s Implications for Payers, Providers, and Manufacturers
IPD Analytics has released a new report: “The One Big Beautiful Bill Act’s Implications for Payers, Providers, and Manufacturers.” The newly signed bill, H.R.1, introduces impactful changes to federal healthcare policy, including Medicaid, the Affordable Care Act (ACA) Marketplace, Medicare physician payment, and more. The report summarizes these provisions, including sections related to Medicare price negotiations, the temporary Medicare physician pay bump, and updates to the ACA marketplace.